01—Abstract
Summary
Summary of the 8-K filed February 3, 2022. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. (CME) has filed an 8-K report detailing an amendment to its employment agreement with Chairman and CEO Terrence A.
Duffy, extending his tenure through December 31, 2024. This extension underscores the Board's confidence in Mr. Duffy's continued leadership, citing his crucial role in navigating market volatility, integrating acquisitions like NEX Group, and executing strategic partnerships such as the one with Google. The amendment includes a base salary increase to $2 milliona annually, effective January 1, 2022, with no changes to his target bonus or equity award opportunities.
Additionally, Mr. Duffy will receive a one-time special bonus of $5 millionb, payable in March 2022. These compensation adjustments are justified by the Board based on Mr. Duffy's long-term contributions, strategic achievements, and commitment to shareholder value, dividend policy, and employee welfare.
02—Key points
Key Highlights
- Terrence A. Duffy's employment as Chairman and CEO extended through December 31, 2024.
- Annual base salary for Mr. Duffy increased from $1.5 million to $2 million, effective January 1, 2022.
- No changes were made to Mr. Duffy's annual target bonus or equity grant value opportunities.
- A one-time special bonus of $5 million will be paid to Mr. Duffy in March 2022.
- The Board cited Mr. Duffy's leadership during market volatility, strategic partnerships (e.g., Google), and acquisition integration (e.g., NEX Group) as key factors for the contract extension.
- The Board emphasized the importance of Mr. Duffy's continued leadership for delivering shareholder value and maintaining the company's dividend policy.
- Vesting of certain unvested equity awards after December 31, 2023, is linked to employment through December 31, 2024, and subject to a general release.
03—Questions
Frequently Asked Questions
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to announce the amendment and restatement of the employment agreement for CME Group's Chairman and CEO, Terrence A. Duffy, extending his contract and adjusting his compensation.
How does Mr. Duffy's compensation change under the new agreement?
Mr. Duffy's annual base salary increases from $1,500,000 to $2,000,000, effective January 1, 2022. His target annual bonus opportunity and target annual equity grant value remain unchanged. Additionally, he will receive a one-time special bonus of $5 million.
What are the key justifications provided by the Board for extending Mr. Duffy's contract and approving the compensation changes?
The Board cited Mr. Duffy's critical leadership during periods of market volatility, his role in achieving synergies from the NEX Group acquisition, the execution of the strategic partnership with Google, his long-term contributions to shareholder value and the company's dividend policy, and his advocacy in government relations.
Are there any specific conditions related to equity awards in the extended term?
Yes, if Mr. Duffy is employed through December 31, 2024, all outstanding unvested time-vesting equity awards granted after December 31, 2023, will vest. Performance-based equity awards granted during this period will vest or be forfeited based solely on actual performance, with both vesting provisions contingent on Mr. Duffy executing a general release.
04—Continue